It explains the State Farm agent experience with a flow chart of agent progression through the program, and includes agent testimonials. The brochure does not include any test questions, but the website may be used to find local agents who may be willing to share some tips.
The secondary objectives are safety profile and the response rate. Lapatinib, an oral inhibitor of EGFR and HER2, have been shown to be an effective treatment in HER2/neu overexpressing metastatic breast cancer patient who refractory herceptin, taxane, and anthracycline treatment.
250 highest no-effect dose for this study was 20 mg/kg/day (approximately equal to the human. 251 clinical exposure based on AUC). 252 Lapatinib was studied for effects on embryo-fetal development in pregnant rats and. 253 rabbits given oral doses of 30, 60, and 120 mg/kg/day.